Oramed Pharmaceuticals Inc ORMP:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/27/22 EDT
4.95quote price arrow up+0.04 (+0.81%)
Volume
5,488
Close
4.91quote price arrow up+0.20 (+4.25%)
Volume
329,839
52 week range
3.74 - 31.54
Loading...
  • Open4.71
  • Day High4.92
  • Day Low4.62
  • Prev Close4.71
  • 52 Week High31.54
  • 52 Week High Date11/03/21
  • 52 Week Low3.74
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap189.33M
  • Shares Out38.56M
  • 10 Day Average Volume0.68M
  • Dividend-
  • Dividend Yield-
  • Beta2.03
  • YTD % Change-65.62

KEY STATS

  • Open4.71
  • Day High4.92
  • Day Low4.62
  • Prev Close4.71
  • 52 Week High31.54
  • 52 Week High Date11/03/21
  • 52 Week Low3.74
  • 52 Week Low Date05/12/22
  • Market Cap189.33M
  • Shares Out38.56M
  • 10 Day Average Volume0.68M
  • Dividend-
  • Dividend Yield-
  • Beta2.03
  • YTD % Change-65.62

RATIOS/PROFITABILITY

  • EPS (TTM)-0.91
  • P/E (TTM)-5.42
  • Fwd P/E (NTM)-5.20
  • EBITDA (TTM)-36.18M
  • ROE (TTM)-32.25%
  • Revenue (TTM)2.93M
  • Gross Margin (TTM)23.21%
  • Net Margin (TTM)-1,219.29%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date07/11/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Oramed Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Oramed Pharmaceuticals Inc. is a pharmaceutical company. It is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. Its pipeline products are ORMD-0801 Type 1, ORM-0801 Type 2 and ORMD-0901. Its flagship product, ORMD-0801, is an orally ingestible insulin capsule. It is anticipated...
Kevin Rakin
Independent Chairman of the Board
Nadav Kidron
President, Chief Executive Officer, Director
Joshua Hexter
Chief Operating and Business Officer
David Silberman CPA
Chief Financial Officer, Treasurer
Netanel Derovan
General Counsel, Company Secretary, Chief Legal Officer
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
New York, NY
10036
United States